Han.biomedical Inc. (TPEX:6999)
Taiwan · Delayed Price · Currency is TWD 28.00
-0.20 (-0.71%)
At close: Oct 8, 2026
Han.biomedical Market Cap
Han.biomedical has a market cap or net worth of 647.24 million as of October 9, 2026. It is the 37,071st most valuable company in the world and the 2,205th biggest in Taiwan. Its market cap has decreased by 26.41% in one year.
Market Cap
647.24M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#2,205 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 31, 2024, Han.biomedical's market cap has decreased from 788.04M to 647.24M, a decrease of -17.87%. That is a compound annual growth rate of -8.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 647.24M | -20.00% |
| Dec 31, 2025 | 809.05M | 20.08% |
| Dec 30, 2024 | 673.74M | -14.51% |
| Jul 31, 2024 | 788.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 23.17B |
| Elixiron Immunotherapeutics (Cayman) Limited | 20.88B |
| Obigen Pharma | 9.21B |
| Intelligene | 7.92B |
| Uwell Biopharma | 5.64B |
| Tripartite Therapeutics | 5.07B |
| Pet Pharm Biotech | 3.08B |
| BIONET Therapeutics | 2.60B |